NCT04503278 2026-04-17
A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
Phase 1 Recruiting
BioNTech SE
Context Therapeutics Inc.
AstraZeneca